Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,541 | -3,465 | -2,330 | -6,453 | -4,705 |
| Depreciation Amortization | 393 | 236 | 104 | 730 | 649 |
| Accounts receivable | 4 | 552 | 562 | 2,900 | 536 |
| Other Working Capital | 2,601 | 1,078 | 2,343 | 4,200 | 1,480 |
| Other Operating Activity | 323 | -1,030 | -400 | -3,663 | -589 |
| Operating Cash Flow | $-2,220 | $-2,629 | $279 | $-2,286 | $-2,629 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | 2,171 | N/A | -8 | -6 |
| Sale Of Investment | 2,172 | N/A | N/A | 2,508 | 2,508 |
| Investing Cash Flow | $2,171 | $2,171 | $N/A | $2,500 | $2,502 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,562 | 3,238 | -45 | 4,111 | 3,201 |
| Debt Repayment | -5,625 | -3,299 | -300 | -5,464 | -4,359 |
| Financing Cash Flow | $-1,063 | $-61 | $-345 | $-1,353 | $-1,158 |
| Exchange Rate Effect | 16 | 15 | 10 | -19 | -7 |
| Beginning Cash Position | 1,389 | 1,389 | 1,389 | 2,547 | 2,547 |
| End Cash Position | 293 | 885 | 1,333 | 1,389 | 1,255 |
| Net Cash Flow | $-1,096 | $-504 | $-56 | $-1,158 | $-1,292 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,220 | -2,629 | 279 | -2,286 | -2,629 |
| Capital Expenditure | -1 | -1 | N/A | -12 | -6 |
| Free Cash Flow | -2,221 | -2,630 | 279 | -2,298 | -2,635 |